Colorectal cancers, which kill more than 900,000 people each year, are notoriously heterogeneous. The cell type and the genetic mutations that give rise to the tumors and the effect of the tumor ...

Cancer is a leading cause of death worldwide, and among all cancers, colorectal cancer ranks second in mortality, responsible ...

A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has ...

GREENVILLE, S.C. (FOX Carolina) - A groundbreaking device is changing how doctors treat colorectal cancer by targeting tumors while sparing the rest of the body from chemotherapy side effects. Hope ...

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer-related deaths worldwide. The mutational landscape of CRC is well ...

Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients, (1) but factors explaining this gap have ...

Phase II study of short-course radiotherapy (SCRT) followed by consolidation chemotherapy with FOLFOXIRI as total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC) patients (pts): ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...

Investigating survival outcomes in patients with early- vs late-onset colorectal cancer with liver metastases. Summary of associations between the colorectal tumor T cell response and sex. *A total of ...

In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...

Colorectal cancer immunotherapy advances as Photobacterium angustum identified to selectively colonize tumors with minimal ...